- Report
- October 2024
- 197 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- March 2025
- 50 Pages
Global
From €2534EUR$2,650USD£2,121GBP
Flunitrazepam is a benzodiazepine drug used as an anesthetic. It is a central nervous system depressant, and is used to induce sleep, reduce anxiety, and relax muscles. It is also used as a premedication before surgery, and is sometimes used to treat insomnia. Flunitrazepam is a Schedule IV controlled substance in the United States, and is not available for medical use in many countries.
Flunitrazepam is a powerful sedative, and can cause respiratory depression, coma, and death if taken in large doses. It is also highly addictive, and can cause physical and psychological dependence. As a result, it is important to use flunitrazepam only under the supervision of a qualified medical professional.
The flunitrazepam market is a small but important part of the anesthetic drugs market. It is used in a variety of medical settings, including pre-operative sedation, anesthesia, and treatment of insomnia.
Some companies in the flunitrazepam market include Roche, Pfizer, Merck, and Sanofi. Show Less Read more